Literature DB >> 11660192

Drug-free research in schizophrenia: an overview of the controversy.

Paul S Appelbaum.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research; Mental Health Therapies; Office for Protection from Research Risks; UCLA School of Medicine

Mesh：

Substances：

Year:  1996        PMID： 11660192

Source DB:  PubMed          Journal:  IRB        ISSN： 0193-7758


× No keyword cloud information.
  10 in total

1.  Public bioethics and research involving persons with mental disorders.

Authors:  P Backlar
Journal:  Community Ment Health J       Date:  1999-10

Review 2.  Psychopharmacological research ethics: special issues affecting US ethnic minorities.

Authors:  Theresa Miskimen; Humberto Marin; Javier Escobar
Journal:  Psychopharmacology (Berl)       Date:  2003-11-18       Impact factor: 4.530

3.  A summary of important documents in the field of research ethics.

Authors:  Bernard A Fischer
Journal:  Schizophr Bull       Date:  2005-09-28       Impact factor: 9.306

4.  Addressing risks to advance mental health research.

Authors:  Ana S Iltis; Sahana Misra; Laura B Dunn; Gregory K Brown; Amy Campbell; Sarah A Earll; Anne Glowinski; Whitney B Hadley; Ronald Pies; James M Dubois
Journal:  JAMA Psychiatry       Date:  2013-12       Impact factor: 21.596

5.  Advance directives for subjects of research who have fluctuating cognitive impairments due to psychotic disorders (such as schizophrenia).

Authors:  P Backlar
Journal:  Community Ment Health J       Date:  1998-06

6.  The long-term effects of placebo in patients with chronic schizophrenia.

Authors:  R J Wyatt; I D Henter; J J Bartko
Journal:  Biol Psychiatry       Date:  1999-10-15       Impact factor: 13.382

7.  Evaluation of "subject advocate" procedures in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia study.

Authors:  T Scott Stroup; Paul S Appelbaum
Journal:  Schizophr Bull       Date:  2005-11-10       Impact factor: 9.306

Review 8.  Weighing the evidence for harm from long-term treatment with antipsychotic medications: A systematic review.

Authors:  Nancy Sohler; Ben G Adams; David M Barnes; Gregory H Cohen; Seth J Prins; Sharon Schwartz
Journal:  Am J Orthopsychiatry       Date:  2015-12-14

9.  Schizophrenia patients' and psychiatrists' perspectives on ethical aspects of symptom re-emergence during psychopharmacological research participation.

Authors:  Laura Weiss Roberts; Teddy D Warner; Khanh P Nguyen; Cynthia M A Geppert; Melinda K Rogers; Brian B Roberts
Journal:  Psychopharmacology (Berl)       Date:  2003-05-17       Impact factor: 4.530

10.  Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations.

Authors:  Samual A Garner; Stuart Rennie; Jintanat Ananworanich; Karine Dube; David M Margolis; Jeremy Sugarman; Randall Tressler; Adam Gilbertson; Liza Dawson
Journal:  J Virus Erad       Date:  2017-04-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.